Clinical Trials - GLUE

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07119125A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRPRECRUITINGPHASE12025-06-272026-032026-01
NCT06597799First-in-human Study of MRT-6160 in Healthy SubjectsCOMPLETEDPHASE12024-08-072025-04-102025-04-10
NCT05546268Study of Oral MRT-2359 in Selected Cancer PatientsRECRUITINGPHASE1, PHASE22022-10-122027-112026-05